Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RebiQoL: Rebif New Formulation Transition in Relapsing MS
NCT00472797Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Apr 2007
- Primary completion
- Feb 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon beta-1a in multiple sclerosis (MS), sponsored by EMD Serono. Started Apr 2007; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00472797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472797.